ask="2.20"
ask_size="1000"
average_daily_volume="348045"
bid="N/A"
bid_size="N/A"
book_value="0.88"
change="+0.10"
change_from_200_day_moving_average="-1.71"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-4.83"
change_From_52_week_low="0.32"
change_in_percent="+5.00%"
close="2.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.11"
ex_dividend_date="N/A"
float_shares="25714000"
high="2.20"
high_52_weeks="6.93"
last_trade_date="2/1/2017"
last_trade_price="2.10"
last_trade_size="3896"
last_trade_time="4:00pm"
low="1.95"
low_52_weeks="1.77"
market_capitalization="64.29M"
moving_average_200_day="3.81"
moving_average_50_day="2.19"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-44.94%"
percent_change_from_50_day_moving_average="-4.29%"
percent_change_from_52_week_high="-69.70%"
percent_change_from_52_week_low="+18.31%"
previous_close="2.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.29"
price_per_sales="156.13"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="5.69"
stock_exchange="NCM"
symbol="TROV"
volume="214963"
weeks_range_52="1.77 - 6.93"
